Prevention of bronchopulmonary dysplasia: Current strategies

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bronchopulmonary dysplasia (BPD) is one of the few diseases affecting premature infants that have continued to evolve since its first description about half a century ago. The current form of BPD, a more benign and protracted respiratory failure in extremely preterm infants, is in contrast to the original presentation of severe respiratory failure with high mortality in larger premature infants. This new BPD is end result of complex interplay of various antenatal and postnatal factors causing lung injury and subsequent abnormal repair leading to altered alveolar and vascular development. The change in clinical and pathologic picture of BPD over time has resulted in new challenges in developing strategies for its prevention and management. While some of these strategies like Vitamin A supplementation, caffeine and volume targeted ventilation have stood the test of time, others like postnatal steroids are being reexamined with great interest in last few years. It is quite clear that BPD is unlikely to be eliminated unless some miraculous strategy cures prematurity. The future of BPD prevention will probably be a combination of antenatal and postnatal strategies acting on multiple pathways to minimize lung injury and abnormal repair as well as promote normal alveolar and vascular development.

Original languageEnglish (US)
Pages (from-to)841-851
Number of pages11
JournalChinese Journal of Contemporary Pediatrics
Volume19
Issue number8
DOIs
StatePublished - Aug 25 2017

Fingerprint

Bronchopulmonary Dysplasia
Lung Injury
Respiratory Insufficiency
Infant, Premature, Diseases
Blood Vessels
Extremely Premature Infants
Caffeine
Vitamin A
Premature Infants
Ventilation
Steroids
Mortality

Keywords

  • Bronchopulmonary dysplasia
  • Premature infant
  • Prevention
  • Strategy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Prevention of bronchopulmonary dysplasia : Current strategies. / Jain, Deepak; Bancalari, Eduardo.

In: Chinese Journal of Contemporary Pediatrics, Vol. 19, No. 8, 25.08.2017, p. 841-851.

Research output: Contribution to journalArticle

@article{c916c03ee9ef4c748fe56f9bc30bf7d8,
title = "Prevention of bronchopulmonary dysplasia: Current strategies",
abstract = "Bronchopulmonary dysplasia (BPD) is one of the few diseases affecting premature infants that have continued to evolve since its first description about half a century ago. The current form of BPD, a more benign and protracted respiratory failure in extremely preterm infants, is in contrast to the original presentation of severe respiratory failure with high mortality in larger premature infants. This new BPD is end result of complex interplay of various antenatal and postnatal factors causing lung injury and subsequent abnormal repair leading to altered alveolar and vascular development. The change in clinical and pathologic picture of BPD over time has resulted in new challenges in developing strategies for its prevention and management. While some of these strategies like Vitamin A supplementation, caffeine and volume targeted ventilation have stood the test of time, others like postnatal steroids are being reexamined with great interest in last few years. It is quite clear that BPD is unlikely to be eliminated unless some miraculous strategy cures prematurity. The future of BPD prevention will probably be a combination of antenatal and postnatal strategies acting on multiple pathways to minimize lung injury and abnormal repair as well as promote normal alveolar and vascular development.",
keywords = "Bronchopulmonary dysplasia, Premature infant, Prevention, Strategy",
author = "Deepak Jain and Eduardo Bancalari",
year = "2017",
month = "8",
day = "25",
doi = "10.7499/j.issn.1008-8830.2017.08.001",
language = "English (US)",
volume = "19",
pages = "841--851",
journal = "Chinese Journal of Contemporary Pediatrics",
issn = "1008-8830",
publisher = "Xiangya Hospital of CSU",
number = "8",

}

TY - JOUR

T1 - Prevention of bronchopulmonary dysplasia

T2 - Current strategies

AU - Jain, Deepak

AU - Bancalari, Eduardo

PY - 2017/8/25

Y1 - 2017/8/25

N2 - Bronchopulmonary dysplasia (BPD) is one of the few diseases affecting premature infants that have continued to evolve since its first description about half a century ago. The current form of BPD, a more benign and protracted respiratory failure in extremely preterm infants, is in contrast to the original presentation of severe respiratory failure with high mortality in larger premature infants. This new BPD is end result of complex interplay of various antenatal and postnatal factors causing lung injury and subsequent abnormal repair leading to altered alveolar and vascular development. The change in clinical and pathologic picture of BPD over time has resulted in new challenges in developing strategies for its prevention and management. While some of these strategies like Vitamin A supplementation, caffeine and volume targeted ventilation have stood the test of time, others like postnatal steroids are being reexamined with great interest in last few years. It is quite clear that BPD is unlikely to be eliminated unless some miraculous strategy cures prematurity. The future of BPD prevention will probably be a combination of antenatal and postnatal strategies acting on multiple pathways to minimize lung injury and abnormal repair as well as promote normal alveolar and vascular development.

AB - Bronchopulmonary dysplasia (BPD) is one of the few diseases affecting premature infants that have continued to evolve since its first description about half a century ago. The current form of BPD, a more benign and protracted respiratory failure in extremely preterm infants, is in contrast to the original presentation of severe respiratory failure with high mortality in larger premature infants. This new BPD is end result of complex interplay of various antenatal and postnatal factors causing lung injury and subsequent abnormal repair leading to altered alveolar and vascular development. The change in clinical and pathologic picture of BPD over time has resulted in new challenges in developing strategies for its prevention and management. While some of these strategies like Vitamin A supplementation, caffeine and volume targeted ventilation have stood the test of time, others like postnatal steroids are being reexamined with great interest in last few years. It is quite clear that BPD is unlikely to be eliminated unless some miraculous strategy cures prematurity. The future of BPD prevention will probably be a combination of antenatal and postnatal strategies acting on multiple pathways to minimize lung injury and abnormal repair as well as promote normal alveolar and vascular development.

KW - Bronchopulmonary dysplasia

KW - Premature infant

KW - Prevention

KW - Strategy

UR - http://www.scopus.com/inward/record.url?scp=85029791144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029791144&partnerID=8YFLogxK

U2 - 10.7499/j.issn.1008-8830.2017.08.001

DO - 10.7499/j.issn.1008-8830.2017.08.001

M3 - Article

C2 - 28774356

AN - SCOPUS:85029791144

VL - 19

SP - 841

EP - 851

JO - Chinese Journal of Contemporary Pediatrics

JF - Chinese Journal of Contemporary Pediatrics

SN - 1008-8830

IS - 8

ER -